Product Code: POLYPOSIS-25
From £445.00
Registration closed: 30/11/2024
Applicable to any lab undertaking molecular genetic testing for disorders associated with polyposis – Familial adenomatous polyposis (FAP) and MUTYH-associated polyposis (MAP).
CNV, MLPA, NGS, Panel testing, Sanger sequencing, Single gene testing, Targeted testing
English, German
DNA (in TE Buffer)
Yes
The scheme is designed to assess the entire diagnostic pipeline of a laboratory, including sample receipt and processing, analytical processing (genotyping), and reporting (biological and clinical interpretation of the test result) in the context of a clinical referral, as well as reporting clarity, content and clerical accuracy.
Four mock clinical cases with matching samples, one case is optional for MUTYH testing.
Approximately 2.0µg DNA per sample is provided. Complete information will be available in scheme instructions.
Participants will receive an individual report including educational advice and a scheme report which includes additional information from the cohort of participants including geographical spread, methodologies employed, common errors, learning points and scheme statistics allowing participants to benchmark their results.
Each laboratory will also receive a single certificate listing all EQAs participated in with performance result for each year.
No restrictions on number of participants. Open to laboratories from ALL countries (note: some restrictions may apply*)
*Sanctions, delivery network exceptions, restrictions on importation etc.
added wishlist!
View Wishlist
View Wishlist
Express your interest in ''.